Launches its semaglutide injection - Sun Pharmaceutical Industries Ltd

Code BSE: 524715 NSE:

Sun Pharma launches its semaglutide injection under the brand names, Noveltreat and Sematrinity in India Commenting on the launch, Kirti Ganorkar, Managing Director, Sun Pharmaceutical Industries Ltd, said, “With the launch of Noveltreat and Sematrinity, our endeavour is to provide a high-quality, affordable therapy to a wider patient community in India. We are offering a comprehensive range, backed by our decades of expertise in manufacturing complex medicines. To further support patients, we are also introducing a holistic patient support program intended to guide them throughout their treatment journey”.